Integrating AI/Ml With Disease Biology To Identify Differentiated Novel Mash Targets

•  Leveraging multi-modal patient data and AI to discover relevant pathways improving target prioritization and accelerating development decision-making
• “Integrating AI/ML with high-dimensional assays to discover novel targets” Leveraging deep biological datasets to build differentiated strategies and maximize translational confidence
• Applying machine learning-enabled discovery strategies to improve therapeutic precision, strengthening pipeline differentiation and increasing future clinical success potential

Speakers:

Santhosh Satapati

Senior Director, Metabolic Diseases

Insitro